UChicago Medicine Faculty Physicians
Richard A. Larson, MD
Richard A. Larson, MD
UChicago Medicine Faculty Physicians
Director, Hematologic Malignancies Program
Specialties
- Hematology and Oncology (Cancer)
Locations
- Chicago - Hyde Park
- About
- Specialties & Areas of Expertise
- Locations & Patient Information
- Education & Research
- Accepted Insurance
- External Professional Relationships
Richard A. Larson, MD, is director of the Hematologic Malignancies Clinical Research Program at the University of Chicago. He was the director of the Leukemia Clinical Research Program from 1983 to 2000, during which time he established the medical center's allogeneic blood and marrow transplant program.
Dr. Larson maintains an active clinical practice at the University of Chicago Medicine, and his expertise is widely sought for consultations regarding leukemias and myelodysplastic syndromes.
His current research interests include clinical trials in hematologic malignancies and stem cell transplantation, experimental therapeutics, the determinants of response to therapy in leukemia and myelodysplastic syndromes, and the etiology of therapy-related leukemias.
Dr. Larson is the past chairman of the Leukemia Committee of the Cancer and Leukemia Group B where he directed a large portfolio of clinical trials and ancillary laboratory studies in acute and chronic leukemias. He has also served as a member of the Hematology Subspecialty Board of the American Board of Internal Medicine.
An active researcher, Dr. Larson has published more than 400 papers, reviews, and book chapters on clinical and laboratory studies in human leukemias. He has served on the editorial boards of BLOOD, the Journal of Clinical Oncology and Leukemia.
He also actively participates in the training of 21 fellows in Hematology/Oncology within the Department of Medicine.
Dr. Larson maintains an active clinical practice at the University of Chicago Medicine, and his expertise is widely sought for consultations regarding leukemias and myelodysplastic syndromes.
His current research interests include clinical trials in hematologic malignancies and stem cell transplantation, experimental therapeutics, the determinants of response to therapy in leukemia and myelodysplastic syndromes, and the etiology of therapy-related leukemias.
Dr. Larson is the past chairman of the Leukemia Committee of the Cancer and Leukemia Group B where he directed a large portfolio of clinical trials and ancillary laboratory studies in acute and chronic leukemias. He has also served as a member of the Hematology Subspecialty Board of the American Board of Internal Medicine.
An active researcher, Dr. Larson has published more than 400 papers, reviews, and book chapters on clinical and laboratory studies in human leukemias. He has served on the editorial boards of BLOOD, the Journal of Clinical Oncology and Leukemia.
He also actively participates in the training of 21 fellows in Hematology/Oncology within the Department of Medicine.
Specialties
Areas of Expertise
UChicago Medicine Duchossois Center for Advanced Medicine - Hyde Park5758 S. Maryland Ave., Chicago IL 606371-888-824-0200
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Practicing Since
- 1977
Languages Spoken
- English
Medical Education
- Stanford University School of Medicine
Residency
- University of Chicago Medicine
Fellowship
- University of Chicago Medicine
Memberships & Medical Societies
- American Association for Cancer Research
- American Society of Hematology
- American Society of Clinical Oncology
News & Research
Insurance
- Aetna Better Health *see insurance page
- Aetna HMO (specialists only)
- Aetna Medicare Advantage HMO & PPO
- Aetna POS
- Aetna PPO
- BCBS Blue Precision HMO (specialists only)
- BCBS HMO (HMOI) (specialists only)
- BCBS Medicare Advantage HMO & PPO
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare *see insurance page
- Humana Medicare Advantage Choice PPO
- Humana Medicare Advantage Gold Choice PFFS
- Humana Medicare Advantage Gold Plus HMO
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice Plus POS/PPO
- United Choice HMO (specialists only)
- United Options (PPO)
- United Select (HMO & EPO) (specialists only)
- United W500 Emergent Wrap
- University of Chicago Health Plan (UCHP)
Our list of accepted insurance providers is subject to change at any time. You should contact your insurance company to confirm UChicago Medicine participates in their network before scheduling your appointment. If you have questions regarding your insurance benefits at UChicago Medicine, please contact our financial counseling team at OPSFinancialCounseling@uchospitals.edu.
UChicago Medicine is committed to fostering a corporate culture of ethical behavior and integrity in all matters related to compliance with the laws and regulations that govern the delivery of healthcare. This aspiration is central to supporting patient care, research, and teaching at UChicago Medicine.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.
Some of our physicians and health professionals collaborate with external pharmaceutical, medical device, or other medical related entities to develop new treatments and products to improve clinical outcomes for patients. In some instances, the physician has ownership interests in the external entity and/or is compensated for advising or speaking about the entity’s products or treatments. These payments may include compensation for consulting and speaking engagements, equity, and/or royalties for products invented by our physicians. To assure objectivity and integrity in patient care, UChicago Medicine requires all physicians and health professionals to report their relationships and financial interests with external entities on an annual basis. This information is used to review relationships and transactions that might give rise to potential financial conflicts of interest, and when considered to be significant a management plan to mitigate any biases is created.
If you are a patient at UChicago Medicine and would like more information about your physician’s external relationships, please talk with your physician. You may also visit the Centers for Medicare & Medicaid Services (CMS) Open Payments website at https://openpaymentsdata.cms.gov/ . CMS Open Payments is a national disclosure program that promotes a more transparent and accountable health care system. It houses a publicly accessible database of payments that reporting entities, including drug and medical device companies, make to covered recipients like physicians and hospitals.
Information in the CMS Open Payments database could potentially contain inaccurately reported and out of date payment information. All information is open to personal interpretation, if there are questions about the data, patients and their advocates should speak directly to their health care provider for a better understanding.